TuHURA Biosciences logo

TuHURA Biosciences

HURA | NASDAQ
Chart Builder DCF Calculator
$1.33
-$0.06 (-4.32%)
At close: Nov 16, 2026, 4:00 PM ET
$1.37
+$0.04 (+3.01%)
After-hours: Nov 16, 2026, 7:59 PM ET
-4.32%

Rating

Updated: Nov 16, 2026
30.2
+1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #794/1021 (Top 78%)

Key Statistics

Market Data

Market Cap $84.76M
1D Range
1.27 1.47
52W Range
0.44 3.15

Valuation (TTM)

PE -2.66
PB 4.47
EV/EBITDA -3.30

Valuation (NTM)

Forward PE N/A
Forward PEG 0.28
Price Target $9.00
Loading financial charts...

Profile

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies des...

Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Feb 22, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$9.50
Upside
+614.29%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.